Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults

Autor: Christer Janson, Birger Norderud Lærum, Thomas Sandström, Paula Kauppi, Celeste Porsbjerg, Tina Skjold, Vibeke Backer, Leif Bjermer, Hannu Kankaanranta, Bo Lundbäck, Dora Ludviksdottir, Jussi Karjalainen, Sverre Lehman, Lauri Lehtimäki, Alan Altraja, Unnur S. Bjornsdottir, Barbro Dahlén, Charlotte Suppli Ulrik
Přispěvatelé: Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland, Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences, University of Tampere
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Biolääketieteet - Biomedicine
diagnosis
Respiratory Medicine and Allergy
prevalence
Placebo-controlled study
Review Article
macromolecular substances
law.invention
03 medical and health sciences
0302 clinical medicine
Quality of life (healthcare)
Randomized controlled trial
law
immune system diseases
Vocal cord dysfunction
Medicine
030212 general & internal medicine
Intensive care medicine
Asma
Asthma
Lungmedicin och allergi
lcsh:RC705-779
business.industry
severe
Sisätaudit - Internal medicine
Öndunarfærasjúkdómar
Guideline
lcsh:Diseases of the respiratory system
medicine.disease
Sjúkdómsgreining
3. Good health
Review article
respiratory tract diseases
Obstructive sleep apnea
co-morbidities
030228 respiratory system
business
guideline
management
Zdroj: Porsbjerg, C, Ulrik, C, Skjold, T, Backer, V, Laerum, B, Lehman, S, Janson, C, Sandstrøm, T, Bjermer, L, Dahlen, B, Lundbäck, B, Ludviksdottir, D, Björnsdóttir, U, Altraja, A, Lehtimäki, L, Kauppi, P, Karjalainen, J & Kankaanranta, H 2018, ' Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults ', European Clinical Respiratory Journal, vol. 5, no. 1, 1440868 . https://doi.org/10.1080/20018525.2018.1440868
European Clinical Respiratory Journal
European Clinical Respiratory Journal, Vol 5, Iss 1 (2018)
Popis: Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma (‘difficult asthma’) should undergo systematic assessment, in order to differentiate between true severe asthma, and ‘difficult-to-treat’ patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.
Databáze: OpenAIRE